阿斯利康和默沙东发布了2025年上半年的业绩报告。阿斯利康上半年总营收280.45亿美元，同比增长11%，其中产品收入266.7亿美元，同比增长10%；经营利润71.82亿美元，同比增长24%。美国市场贡献最高，达到119.7亿美元，占总收入的43%；中国区收入35.15亿美元，增长5%，占总收入的13%。默沙东上半年总营收313.35亿美元，同比下降2%，制药业务营收为276.88亿美元，同比...
Source Link阿斯利康和默沙东发布了2025年上半年的业绩报告。阿斯利康上半年总营收280.45亿美元，同比增长11%，其中产品收入266.7亿美元，同比增长10%；经营利润71.82亿美元，同比增长24%。美国市场贡献最高，达到119.7亿美元，占总收入的43%；中国区收入35.15亿美元，增长5%，占总收入的13%。默沙东上半年总营收313.35亿美元，同比下降2%，制药业务营收为276.88亿美元，同比...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.